Collegium Pharmaceutical (COLL) Debt Ratio (2014 - 2026)

Collegium Pharmaceutical's Debt Ratio history runs 13 years deep, the most recent figure standing at 0.34 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 0.52% year-over-year to 0.34 in Q1 2026; TTM through Mar 2026 was 0.34, a 0.52% decrease from a year earlier, with the FY2025 full-year figure at 0.34, down 6.81% from the prior year.
• Debt Ratio fell to 0.34 in Q1 2026 per COLL's latest filing, from 0.34 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.5 in Q1 2022 and bottomed at 0.3 in Q2 2024.
• The 5-year median for Debt Ratio is 0.37 (2024), against an average of 0.39.
• Across the five-year window, Debt Ratio soared 200.07% in 2022 and slipped 26.81% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.48 in 2022, then fell by 25.73% to 0.35 in 2023, then rose by 4.4% to 0.37 in 2024, then declined by 6.81% to 0.34 in 2025, then slipped by 0.89% to 0.34 in 2026.
• Per Business Quant, the three latest COLL Debt Ratio figures stand at 0.34 (Q1 2026), 0.34 (Q4 2025), and 0.31 (Q3 2025).